GAITHERSBURG, Md., Feb. 20, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences in March 2015:
- Cowen and Company 35th Annual Health Care Conference
March 2, 2015
Presentation: 2:10PM Eastern
- Credit Suisse Under Followed Opportunities Conference
March 10, 2015
- MaidStone Life Sciences LLC 5th Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference
March 26, 2015
For the Cowen and Company conference, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcast will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
CONTACT: Investors Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 BurrowsR@ebsi.com Media Contact: Tracey Schmitt Vice President, Global Public Affairs and Corporate Responsibility 240-631-3200 SchmittT@ebsi.com
Source:Emergent BioSolutions Inc.